Clover Health Jumps as CMS Approves Firm’s Expansion Plans for 2022 By Investing.com

© Reuters.

By Dhirendra Tripathi

Investing.com – Clover Health stock (NASDAQ:) gained more than 2% Wednesday as the Centers for Medicare and Medicaid Services approved the company’s service area expansion to operate in 101 new counties.

Effective January 1, the approval brings Clover’s total coverage area for its Medicare advantage plans to 209 counties across nine states.

The new counties are in states of Georgia, New Jersey, South Carolina, Texas, and Alabama – a new territory for the company.

Individuals eligible for Medicare in any of the 209 counties can sign up for Clover’s plans during the annual election period, which runs from October 15 to December 7, the company said.

The company last month reported a doubling of revenue and memberships in the second quarter.

Clover is on a $1.6 billion annual revenue run rate based on the second quarter results, Clover Health CFO Joe Wagner said in an August 11 note.

Second-quarter revenue grew 140% to $412.5 million. But the company made a loss as against a profit last time because of a higher salary bill and administrative expenses.

 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*